Sofía Matilla-Almazán (Sofía Del Carmen)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Sentinel Lymph Node

Tyrosine Kinase

Top Venues

Cancer research

Scientific reports

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Adrián Sánchez-Fdez, Sofía Matilla-Almazán, Juan Carlos Montero, Sofía Del Carmen, Mar Abad, Sara García-Alonso, Somshuvra Bhattacharya, Kristin Calar, Pilar de la Puente, Alberto Ocaña, Atanasio Pandiella, Azucena Esparís-Ogando
The WNK1-ERK5 route plays a pathophysiological role in ovarian cancer and limits therapeutic efficacy of trametinib. Clinical and translational medicine 13 (4) (2023)
Sofía Matilla-Almazán, Luis-Antonio Corchete, Cristina González Velasco, Julia Sanz, José Antonio Alcazar, Jacinto García, Ana Isabel Rodríguez, María Del Rosario Vidal Tocino, Alba Rodriguez, Luis Alberto Pérez-Romasanta, Jose Maria Sayagues Manzano, Mar Abad
High-Risk Clinicopathological and Genetic Features and Outcomes in Patients Receiving Neoadjuvant Radiochemotherapy for Locally Advanced Rectal Cancer. Cancers 13 (13) (2021)
Jose J G Marin, Paula Sanchon-Sanchez, Candela Cives-Losada, Sofía Matilla-Almazán, Jesús M González-Santiago, Maria J Monte, Rocío I R Macías
Novel Pharmacological Options in the Treatment of Cholangiocarcinoma: Mechanisms of Resistance. Cancers 13 (10) (2021)
Sofía Matilla-Almazán, Luis-Antonio Corchete, Ruth Gervas, Alba Rodriguez, María Garcia, José Antonio Álcazar, Jacinto García, Oscar Bengoechea, Luis Muñoz-Bellvis, Jose Maria Sayagues Manzano, Mar Abad
Prognostic implications of EGFR protein expression in sporadic colorectal tumors: Correlation with copy number status, mRNA levels and miRNA regulation. Scientific reports 10 (1) (2020)
Adrián Blanco-Gómez, Lourdes Hontecillas-Prieto, Roberto Corchado-Cobos, Natalia García-Sancha, Nélida Salvador, Andrés Castellanos-Martín, María Del Mar Sáez-Freire, Marina Mendiburu-Eliçabe, Diego Alonso López, Javier De Las Rivas, Mar Lorente, Ana García-Casas, Sofía Matilla-Almazán, María Del Mar Abad-Hernández, Juan Jesús Cruz Hernández, César Augusto Rodríguez-Sánchez, Juncal Claros-Ampuero, Maria-Begoña Garcia-Cenador, Javier García-Criado, Akira Orimo, Thomas Gridley, Jesús Pérez Losada, Sonia Castillo-Lluva
Stromal SNAI2 Is Required for ERBB2 Breast Cancer Progression. Cancer research 80 (23) (2020)